Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, ...
MAPLE GROVE, Minn., May 20, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), today announced the recent ...
Restasis is a brand-name eye drop that’s prescribed for chronic dry eye. The medication is available in single-use and multiuse vials. Restasis is a type of immunosuppressant. Restasis is approved by ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) on Tuesday announced that the U.S. Food and Drug Administration has approved its cyclosporine ophthalmic emulsion 0.05%, a sterile formulation supplied ...
The US Food and Drug Administration (FDA) on Wednesday denied Allergan's third citizen petition attempting to block the agency from approving generic versions of the company's blockbuster Restasis ...
Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...
These are single-use vials and should be discarded after each use.For questions about ordering, please call Upsher-Smith at 1-800-654-2299. About BoraFounded in 2007, Bora Pharmaceuticals ("Bora" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results